Niu Wei, Yang Xiaoxiao, Yan Hao, Yu Zanzhe, Li Zhenyuan, Lin Xinghui, Gu Leyi, Ni Zhaohui, Fang Wei
Department of Nephrology, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China.
Front Med (Lausanne). 2022 Jun 2;9:748934. doi: 10.3389/fmed.2022.748934. eCollection 2022.
Association of peritoneal protein clearance (Pcl) with outcomes in patients with peritoneal dialysis (PD) is uncertain. Thus, we aimed to investigate its impact on cardiovascular events and all-cause mortality in patients with PD and factors associated with Pcl.
Prevalent patients with PD from January 2014 to April 2015 in the center of Renji Hospital were enrolled. At the time of enrollment, serum and dialysate samples were collected to detect biochemical parameters and Angiopoietin-2-Tie2 system cytokines. Mass transfer area coefficient of creatinine (MTACcr) and Pcl were calculated. Patients were dichotomized into two groups by the median Pcl level (68.5 ml/day) and were followed up prospectively until the end of the study (1 October 2018).
A total of 318 patients with PD [51.2% men, mean age 56.7 ± 14.3 y, median PD duration 31.5 (12.1-57.2) months] were enrolled. Among them, 25.7% were comorbid with diabetes and 28.6% had a history of cardiovascular disease (CVD). After being followed up for up to 43.9 (24.2-50.3) months, 63 had developed cardiovascular events, and 81 patients were died. Among them, the high Pcl group had occurred 39 cardiovascular events and 51 deaths, and the low Pcl group had 24 cardiovascular events and 30 deaths. Kaplan-Meier analysis showed that both the occurrence of cardiovascular events and all-cause mortality were increased in patients with high Pcl. However, after adjusting for important confounders and serum Angiopoietin-2 (Angpt-2) level, Pcl was still an independent risk factor for cardiovascular events [hazard ratio (HR) = 1.006 (1.000-1.012), = 0.038] but not mortality. On multivariate regression analysis, serum albumin, MTACcr, and body mass index (BMI) were found to be independently associated with Pcl.
High Pcl is an independent risk factor for cardiovascular events but not all-cause mortality. The prediction of cardiovascular events by Pcl was independent of serum Angpt-2.
腹膜蛋白清除率(Pcl)与腹膜透析(PD)患者预后之间的关联尚不确定。因此,我们旨在研究其对PD患者心血管事件和全因死亡率的影响以及与Pcl相关的因素。
纳入2014年1月至2015年4月在仁济医院中心的PD现患患者。入选时,收集血清和透析液样本以检测生化参数和血管生成素-2-酪氨酸激酶2系统细胞因子。计算肌酐的质量转移面积系数(MTACcr)和Pcl。根据Pcl水平中位数(68.5 ml/天)将患者分为两组,并进行前瞻性随访直至研究结束(2018年10月1日)。
共纳入318例PD患者[男性占51.2%,平均年龄56.7±14.3岁,PD中位病程31.5(12.1 - 57.2)个月]。其中,25.7%合并糖尿病,28.6%有心血管疾病(CVD)病史。随访长达43.9(24.2 - 50.3)个月后,63例发生心血管事件,81例患者死亡。其中,高Pcl组发生39例心血管事件和51例死亡,低Pcl组发生24例心血管事件和30例死亡。Kaplan-Meier分析显示,高Pcl患者的心血管事件发生率和全因死亡率均增加。然而,在调整重要混杂因素和血清血管生成素-2(Angpt-2)水平后,Pcl仍是心血管事件的独立危险因素[风险比(HR)= 1.006(1.000 - 1.012),P = 0.038],但不是死亡率的独立危险因素。多因素回归分析发现,血清白蛋白、MTACcr和体重指数(BMI)与Pcl独立相关。
高Pcl是心血管事件的独立危险因素,但不是全因死亡率的独立危险因素。Pcl对心血管事件的预测独立于血清Angpt-2。